In 2018, President Trump signed a federal Right to Try Act into law, allowing dying patients access to experimental treatments. Although there is an as-yet-unapproved treatment for Amyotrophic Lateral Sclerosis (ALS) currently in Phase 3 trials, ALS patients have to date not been able to access this treatment under Right to Try. (STATNews)